JG, S., J, K., EH, B., & P, L. (1996). 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 11(3), 367. https://doi.org/10.1002/jbmr.5650110310
Chicago Style (17th ed.) CitationJG, Sterck, Klein-Nulend J, Burger EH, and Lips P. "1,25-dihydroxyvitamin D3-mediated Transforming Growth Factor-beta Release Is Impaired in Cultured Osteoblasts from Patients with Multiple Pituitary Hormone Deficiencies." Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 11, no. 3 (1996): 367. https://doi.org/10.1002/jbmr.5650110310.
MLA (9th ed.) CitationJG, Sterck, et al. "1,25-dihydroxyvitamin D3-mediated Transforming Growth Factor-beta Release Is Impaired in Cultured Osteoblasts from Patients with Multiple Pituitary Hormone Deficiencies." Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, vol. 11, no. 3, 1996, p. 367, https://doi.org/10.1002/jbmr.5650110310.
